Brielle Benyon
Articles
Lenvatinib/Pembrolizumab Boosts Outcomes For Next Line Therapy in Advanced Renal Cell Carcinoma
June 09, 2022
Article
Frontline treatment with lenvatinib plus pembrolizumab decreased risk of disease progression or death by 50% compared with sunitinib in advanced renal cell carcinoma.
Prognostic Awareness Impacts QOL in Patients With Myeloma
December 16, 2021
Article
Patients with myeloma who reported that their disease was incurable had lower quality of life. However, many patients may also have misconceptions about the curability of their disease.
Patient Mental Health Key Factor in Cancer Clinical Trial Perception
December 14, 2021
Article
If patients with cancer experience depression or anxiety, it can result in low clinical trial enrollment.
UK Study of Real-World Data Shows Survival Benefit of Cabozantinib vs Axitinib in Pre-Treated RCC
September 21, 2021
Article
Patients with advanced RCC who received prior VEGF-targeted therapy tend to have longer survival outcomes with cabozantinib than with axitinib.
COVID-19 Pandemic Emphasizes Disparities in Cancer Care
September 17, 2021
Podcast
“We’ve had periods of time where things were shut down. We do have telemedicine, that was expanded, but telemedicine doesn’t work for everyone. If you don’t have internet access, if you don’t have the ability to understand the technology….”
Neurotoxicity With Cilta-cel: Early Intervention Can Improve Outcomes in R/R Myeloma
August 20, 2021
Article
In the cohort of patients with multiple myeloma, there were no grade 3 or higher neurotoxicities.
Oncology Nurses Must Stress Importance of Medication Adherence
August 10, 2021
Article
With a newfound abundance of available oral cancer therapies, it has become necessary for oncology nurses to ensure that their patients are adhering to treatment.
Prompt Treatment of CAR T-Cell Therapy-Related AEs Can Prevent Long-Term Lasting Effects
July 05, 2021
Article
Data presented at the European Hematology Association 2021 Virtual Meeting revealed that CAR T-cell therapy-related adverse effects can be managed.
Patients With Advanced ESCC Experience Improved Survival Outcomes With Addition of Nivolumab to Ipilimumab or Chemotherapy
June 21, 2021
Article
Survival outcomes in the frontline treatment of patients with unresectable advanced or metastatic esophageal squamous cell carcinoma were improved when nivolumab was added alongside either ipilimumab or chemotherapy.
COVID-19 Vaccine Benefits Outweigh Risk, Despite Cardiac Concerns, Expert Says
June 18, 2021
Article
Many patients with cancer may feel uneasy about the COVID-19 vaccines, especially as new stories break about potential heart complications. However, most patients should get the shot as soon as possible, says Brahm Segal, MD.